“The company is commercialising its Promarker D predictive test for diabetic kidney disease. The...
$1.1m tax rebate booster for Proteomics coffers – The West Australian
“The Federal Government’s R&D tax incentive rebate program is designed to encourage companies to carry out research that could potentially benefit Australia by providing a tax offset of 43.5 per cent for eligible R&D work and expenditure. Companies who qualify for the 43.5 per cent offset are also required to have an aggregated turnover of less than $20 million per annum.“